About Index Trending news
Lists
Pricing
Mesoblast

Mesoblast

Mesoblast

Mesoblast Limited (ASX:MSB USOTC:MBLTY) is developing novel biotherapeutics derived from its proprietary cellbased technologies.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital
$6,200,000
Australian Government for Research & Development
Employees

Team size

50+
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Mesoblast makes some noise.